A fall 2016 report by Research and Markets states the cold form blister packaging market should hit U.S. $8.63 billion by 2024. Growing demand from the pharmaceutical industry and a high requirement of cold forming packs due to favorable product features are driving the growth.
The medicine or device may be a home-run product, but if consumers aren’t using the product correctly, it has little chance of success. And if the consumers cannot even open the package to get to the product inside, it has zero chance.
It’s 2017! If you are expecting groundbreaking news from the world of pharmaceutical safety, you may have to wait a while. Let’s get a quick status report.
Klöckner Pentaplast will present the latest range of pharmaceutical packaging solutions and services at Pharmapack 2017 on February 1-2, 2017, in Paris, France.
Healthcare is a booming business in the United States, and that fact is creating tremendous growth opportunities for both pharmaceutical and medical device packaging.
As fall 2016 kicks in, pharmaceutical manufacturers and those involved in the supply chain are grappling with the roll out of The Drug Supply Chain Security Act (DSCSA).
As the newest member of Pharma Tech’s leadership team, Kaneps’ primary role will be developing and maintaining new supply chain relationships with both current and potential customers.